Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89601-89650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05226559
Effectiveness of Multimodal Physical Therapy in Migraine
NARecruiting
36 participants
Started: Feb 24, 2022 · Completed: May 31, 2025
5 conditions1 sponsor1 location
NCT05102240
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
N/AActive, not recruiting
1,800 participants
Started: Feb 24, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT05255978
A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
N/ARecruiting
10,000 participants
Started: Feb 24, 2022 · Completed: Jun 24, 2030
1 condition1 sponsor1 location
NCT04380831
TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis
EARLY_PHASE1Recruiting
15 participants
Started: Feb 24, 2022 · Completed: Dec 22, 2026
1 condition2 sponsors1 location
NCT05193968
Hot Flashes and Neurovascular Function in Women
NARecruiting
120 participants
Started: Feb 24, 2022 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT05256199
Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline
NAActive, not recruiting
1,210 participants
Started: Feb 24, 2022 · Completed: Jun 1, 2027
3 conditions6 sponsors5 locations
NCT04773782
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Feb 24, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor26 locations
NCT05430802
Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIIA-IIIB Resectable NSCLC (FORESEE)
PHASE2Recruiting
40 participants
Started: Feb 24, 2022 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT04908319
Hepatic Histopathology in Urea Cycle Disorders
N/ARecruiting
70 participants
Started: Feb 24, 2022 · Completed: Jun 30, 2026
10 conditions2 sponsors2 locations
NCT05378633
The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?
PHASE2Recruiting
190 participants
Started: Feb 24, 2022 · Completed: Feb 24, 2026
2 conditions1 sponsor1 location
NCT05463562
Multimodal Biomarkers of Electroconvulsive Therapy in Severe and Treatment-resistant Depression
N/ARecruiting
134 participants
Started: Feb 24, 2022 · Completed: Feb 23, 2025
2 conditions1 sponsor1 location
NCT05723133
Visual Feedback on Brushing Technique and Habits on Patient Oral Hygiene
NARecruiting
150 participants
Started: Feb 24, 2022 · Completed: Jul 30, 2024
3 conditions1 sponsor4 locations
NCT05180006
Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy
PHASE2Recruiting
185 participants
Started: Feb 24, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05103943
Amyloidosis TTR Flow Reserve Evaluation
NAActive, not recruiting
50 participants
Started: Feb 24, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT05345158
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
NARecruiting
25 participants
Started: Feb 23, 2022 · Completed: Nov 30, 2030
2 conditions1 sponsor1 location
NCT04255303
Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support
NAActive, not recruiting
347 participants
Started: Feb 23, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors3 locations
NCT05269277
Health System Methods to Improve Nursing Retention Amidst Ongoing COVID-19 Pandemic: a Mixed Method Study
N/AEnrolling by invitation
120 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04879940
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
PHASE2Recruiting
26 participants
Started: Feb 23, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT05014698
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
NAActive, not recruiting
34 participants
Started: Feb 23, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor2 locations
NCT05267509
An Integrated Radio-immunological Approach
N/ARecruiting
40 participants
Started: Feb 23, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors2 locations
NCT05220163
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
NAActive, not recruiting
26,200 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2025
3 conditions8 sponsors3 locations
NCT05237583
Prehabilitation for Patients Awaiting Liver Transplantation
NARecruiting
25 participants
Started: Feb 23, 2022 · Completed: Jul 31, 2025
3 conditions3 sponsors1 location
NCT05463380
Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project
N/ARecruiting
22,000 participants
Started: Feb 23, 2022 · Completed: Oct 13, 2026
1 condition12 sponsors10 locations
NCT04767555
Impact of ILM Peeling in RRD/ I-Peel
NAEnrolling by invitation
250 participants
Started: Feb 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05191121
Improving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI)
NAEnrolling by invitation
99 participants
Started: Feb 23, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04428190
Prebiotic Therapy to Improve Outcomes of Renal Transplant
EARLY_PHASE1Recruiting
60 participants
Started: Feb 23, 2022 · Completed: Dec 15, 2024
1 condition4 sponsors1 location
NCT05230901
Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden
PHASE3Recruiting
300 participants
Started: Feb 23, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06431841
Atropine and Spectacle Combination Treatment (ASPECT): 12-month Results of a Randomized Clinical Trial for Myopia Control
PHASE4Active, not recruiting
111 participants
Started: Feb 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04725916
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
NARecruiting
100 participants
Started: Feb 23, 2022 · Completed: Jul 15, 2026
4 conditions1 sponsor1 location
NCT04799301
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
PHASE1Recruiting
60 participants
Started: Feb 23, 2022 · Completed: Jan 1, 2028
2 conditions1 sponsor1 location
NCT04906746
Ruxolitinib for Cancer Cachexia
EARLY_PHASE1Active, not recruiting
10 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05195450
TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.
NARecruiting
200 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04757168
Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone with the NOGA System
NARecruiting
12 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04997109
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
NARecruiting
267 participants
Started: Feb 23, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors4 locations
NCT05875909
Corneal Flap Transplantation for Macular Hole Repair of High Myopia
NAActive, not recruiting
30 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05117788
Bioneer IRONqPCR ™ RFIA Kit Kit Clinical Evaluation
N/AActive, not recruiting
1,372 participants
Started: Feb 23, 2022 · Completed: Dec 30, 2026
1 condition5 sponsors3 locations
NCT05233462
Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia
NARecruiting
250 participants
Started: Feb 23, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05541601
Prospective Cohort for Early Detection of Liver Cancer
N/ARecruiting
3,000 participants
Started: Feb 23, 2022 · Completed: Jul 31, 2037
2 conditions7 sponsors1 location
NCT05039424
Endoscopic Myotomy of the Pylorus to Improve Emptying and Symptoms Trial
NARecruiting
100 participants
Started: Feb 23, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05349513
Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
NARecruiting
56 participants
Started: Feb 23, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05009771
Postoperative Pain Management of Caesarean Section
N/ARecruiting
100 participants
Started: Feb 23, 2022 · Completed: Jul 31, 2026
3 conditions1 sponsor2 locations
NCT05240976
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
PHASE2Recruiting
80 participants
Started: Feb 23, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT04575961
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
PHASE2Active, not recruiting
33 participants
Started: Feb 22, 2022 · Completed: Mar 1, 2028
4 conditions2 sponsors2 locations
NCT06298006
A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients
N/AActive, not recruiting
57 participants
Started: Feb 22, 2022 · Completed: Jun 30, 2027
1 condition5 sponsors1 location
NCT05042544
The National Australian HCV Point-of-Care Testing Program
N/ARecruiting
40,000 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors56 locations
NCT05204199
Role of Microbiome in BCG Responsiveness Prediction
N/ARecruiting
120 participants
Started: Feb 22, 2022 · Completed: Oct 20, 2025
2 conditions2 sponsors5 locations
NCT05402839
Screening of Malignant Hyperthermia Susceptible Individuals
N/ARecruiting
50 participants
Started: Feb 22, 2022 · Completed: Feb 28, 2041
1 condition1 sponsor1 location
NCT05057702
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NARecruiting
74 participants
Started: Feb 22, 2022 · Completed: Jan 31, 2028
6 conditions6 sponsors7 locations
NCT05114733
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)
NARecruiting
24 participants
Started: Feb 22, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05880407
Pilot Study of Percutaneous Correction of Hallux Valgus
NARecruiting
40 participants
Started: Feb 22, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location